Biotech

All Articles

Lilly, Haya ink $1B biobuck obesity deal to look darker genome

.Eli Lilly's hunt for weight problems intendeds has actually led it to the darker genome. The Big Ph...

ArsenalBio increases $325M, turns far from past lead resource

.Toolbox Biosciences is actually moving on up. The tissue therapy business has added $325 million in...

Lilly- supported weight management biotech reports IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' cannabis make use of medicine fails phase 2b, driving Indivior to reconsider $100M possibility

.Aelis Farma's chances of safeguarding a simple, beneficial decision on a $one hundred thousand poss...

ProKidney halts period 3 trial not needed for tissue treatment authorization

.ProKidney has actually stopped among a set of period 3 tests for its own cell treatment for renal c...

Vaxcyte rises on 'magnificent' 31-valent PCV gain against Pfizer

.Vaxcyte unveiled what experts called "spectacular" period 1/2 information for its own 31-valent pne...

Recursion's brain disease trial reveals insufficient evidence of effectiveness

.Recursion has actually discovered via a very early test of its tech-enabled strategy to medication ...

Acepodia, Pfizer click together for chemistry-based tissue therapy

.Contact it a case of really good chemical make up: Acepodia, a biotech based on Nobel Champion scie...

Praxis epilepsy medication lessens seizures in stage 2 trial

.Praxis Preciseness Medicines has scored an additional midphase succeed in epilepsy this year, with ...

Three execs resign as Dyne posts blended information for DMD prospect

.After escaping a scientific grip several years back, Dyne Rehab has disclosed new period 1/2 data f...